Banque Cantonale Vaudoise Buys Shares of 3,761 Astera Labs, Inc. $ALAB

Banque Cantonale Vaudoise bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, Holdings Channel reports. The fund bought 3,761 shares of the company’s stock, valued at approximately $626,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in shares of Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after acquiring an additional 1,693,918 shares during the last quarter. Amundi boosted its position in shares of Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC bought a new stake in shares of Astera Labs during the 3rd quarter valued at about $209,599,000. BNP Paribas Financial Markets boosted its position in shares of Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after acquiring an additional 960,899 shares during the last quarter. Finally, Voloridge Investment Management LLC bought a new stake in shares of Astera Labs during the 3rd quarter valued at about $131,539,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on ALAB shares. Susquehanna boosted their target price on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. TD Cowen boosted their target price on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Barclays boosted their target price on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Stifel Nicolaus boosted their price objective on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Finally, UBS Group started coverage on Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective for the company. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
• Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
• Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
• Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 280,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $249.19, for a total transaction of $69,773,200.00. Following the completion of the transaction, the chief operating officer owned 615,000 shares in the company, valued at $153,251,850. This represents a 31.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,915,461 shares of company stock worth $358,508,976 over the last quarter. 12.50% of the stock is owned by corporate insiders.

Astera Labs Stock Performance

Shares of ALAB stock opened at $306.88 on Friday. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $315.81. The stock has a 50 day moving average price of $170.39 and a two-hundred day moving average price of $159.79. The company has a market capitalization of $52.60 billion, a P/E ratio of 207.35, a PEG ratio of 3.94 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.